Loading clinical trials...
Loading clinical trials...
Multicenter Prospective Registry for Periprosthetic Fractures After Hip or Knee Arthroplasty
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
To close the gap of missing clinical evidence regarding the treatment of periprosthetic fractures after arthroplasty of the hip or the knee with osteosynthesis. To drive further study hypotheses and to answer unforeseen questions. Main questions to be answered by the registry include (but are not exclusive) the following: 1. Influence of implants on outcome 2. Influence of surgical techniques on outcome 3. Influence of bone grafting on outcome 4. Identification of risk factors for failure 5. Identification of postoperative rehabilitation programs and its possible influence on the outcome 6. Influence of fracture type on outcome 7. To serve as a comparative dataset for future studies with improved implants and techniques
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Missouri Health Care
Columbia, Missouri, United States
Jersey City Medical Center RWJ Barnabas Health
Jersey City, New Jersey, United States
Saint Barnabas Medical Center Livingston
Livingston, New Jersey, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Universitaire Ziekenhuiven Leuven
Leuven, Belgium
Hospital Santa Clara
Bogotá, Colombia
Charité Universitätsmedizin Berlin
Berlin, Germany
BG-Unfallklinik Ludwigshafen
Ludwigshafen, Germany
Universitätsklinikum Münster
Münster, Germany
Hospital Universitario Son Llàtzer
Palma de Mallorca, Spain
Start Date
December 31, 2018
Primary Completion Date
January 31, 2027
Completion Date
March 31, 2027
Last Updated
September 12, 2025
600
ESTIMATED participants
Lead Sponsor
AO Innovation Translation Center
NCT05805774
NCT06909916
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06028971